
BMS-986120
CAS No. 1478712-37-6
BMS-986120( BMS 986120 | BMS986120 )
Catalog No. M12041 CAS No. 1478712-37-6
BMS-986120 (BMS986120)?is a potent, selective, orally bioavailable, and reversible PAR4 antagonist with Kd of 0.098 nM for human PAR4.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 260 | Get Quote |
![]() ![]() |
50MG | 1269 | Get Quote |
![]() ![]() |
100MG | 2025 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameBMS-986120
-
NoteResearch use only, not for human use.
-
Brief DescriptionBMS-986120 (BMS986120)?is a potent, selective, orally bioavailable, and reversible PAR4 antagonist with Kd of 0.098 nM for human PAR4.
-
DescriptionBMS-986120 (BMS986120)?is a potent, selective, orally bioavailable, and reversible PAR4 antagonist with Kd of 0.098 nM for human PAR4; selectivity inhibits PAR4 AP-induced cellular calcium mobilization in HEK cells with IC5o of 0.56 nM, with no activity on PAR1 and PAR2; inhibits human PRP aggregation in response to γ-thrombin in vitro with IC50 of 7.3 nM; demonstrates potent and highly efficacious antithrombotic activity with low bleeding in vivo.Thrombosis Phase 2 Clinical.
-
In Vitro——
-
In Vivo——
-
SynonymsBMS 986120 | BMS986120
-
PathwayGPCR/G Protein
-
TargetPAR
-
RecptorPAR
-
Research AreaCardiovascular Disease
-
IndicationThrombosis
Chemical Information
-
CAS Number1478712-37-6
-
Formula Weight513.587
-
Molecular FormulaC23H23N5O5S2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 3.33 mg/mL (6.48 mM)
-
SMILESCOC1=NN2C(S1)=NC(C(O3)=CC4=C3C=C(OC)C=C4OCC(N=C5N6CCOCC6)=C(S5)C)=C2
-
Chemical Name4-(4-(((6-methoxy-2-(2-methoxyimidazo[2,1-b][1,3,4]thiadiazol-6-yl)benzofuran-4-yl)oxy)methyl)-5-methylthiazol-2-yl)morpholine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Wong PC, et al. Sci Transl Med. 2017 Jan 4;9(371). pii: eaaf5294.
2. Moschonas IC, et al. Platelets. 2017 Dec;28(8):812-821.
3. Wilson SJ, et al. Arterioscler Thromb Vasc Biol. 2017 Dec 21. pii: ATVBAHA.117.310104.
molnova catalog



related products
-
Vorapaxar
A potent, selective and orally active thrombin receptor PAR-1 antagonist with Ki of 8.1 nM.
-
BMS-986120
BMS-986120 (BMS986120)?is a potent, selective, orally bioavailable, and reversible PAR4 antagonist with Kd of 0.098 nM for human PAR4.
-
NBQX disodium salt
Potent, selective and competitive AMPA receptor antagonist. Neuroprotective and anticonvulsant; active in vivo.